Topical 5% 5-fluorouracil versus procedural modalities for squamous cell carcinoma in situ and superficial basal cell carcinoma: A retrospective cohort analysis

MeSH terms

• Administration, Topical
• Carcinoma in Situ* / drug therapy
• Carcinoma in Situ* / pathology
• Carcinoma, Basal Cell* / drug therapy
• Carcinoma, Basal Cell* / pathology
• Carcinoma, Squamous Cell* / drug therapy
• Carcinoma, Squamous Cell* / pathology
• Fluorouracil / therapeutic use
• Humans
• Retrospective Studies
• Skin Neoplasms* / drug therapy
• Skin Neoplasms* / pathology